A new study, recently published in the journal Nature Communications, is leading to a new understanding of how immune cells ...

A Dartmouth study published in Nature Communications reveals that immune cells in the brain use a surprising two-step process ...

By analyzing tissue from patients with Parkinson's disease, and animal and cellular models of the disease, a research team ...

A study by researchers from Fujita University reveals that hypernatremia enhances NFAT5 and NO production in microglia and minocycline mitigates this response. The image above is a schematic showing ...

Immunotherapy that blocks microglial Fcγ receptors prevents dopaminergic neuron loss in Parkinson’s disease, revealing a potential new strategy.

Dominika Pilat, PhD, and Ana Griciuc, PhD, of the Department of Neurology at Massachusetts General Hospital are the lead and senior authors of a paper published in Neuron, "The Gain-of-Function ...

Findings reveal that microglia may serve as a potential therapeutic target for the treatment of hyponatremia-related neurological dysfunctions and osmotic demyelination syndrome (ODS) Low serum sodium ...

Parkinson’s disease has long been defined by the slow, relentless loss of dopamine-producing neurons, with treatments focused ...

Researchers have identified a protein that links brain immune activity, metabolism, and amyloid clearance, suggesting a new ...